Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Late Complications Post-SCT

Bone mass after allogeneic BMT for childhood leukaemia or lymphoma

Abstract

The bone mass was measured by dual energy X-ray absorptiometry in 25 survivors of childhood leukaemia or lymphoma (21 with ALL) who had received TBI and allogeneic BMT a median of 8 years ago (range 4–13). Results were compared with local data on 463 healthy controls and 95 survivors of childhood ALL treated without BMT. Adjusted for sex and age, the mean whole-body bone mineral content (BMC) and bone mineral areal density were significantly less than in healthy controls (0.8 and 0.5 s.d. less than predicted). The reduced BMC was caused by a significantly reduced height for age, whereas bone area for height and BMC for bone area were similar to controls. Less bone mass tended to be related to additional cranial irradiation and age above 20 years at follow-up. Controlled for this, the whole-body bone mass seemed to be unrelated to previous chemotherapy and endocrine status at follow-up and tended to be only marginally less in BMT patients than in ALL survivors treated without BMT. In conclusion, 8 years after allogeneic BMT for childhood leukaemia or lymphoma, the whole-body bone mass was only slightly reduced and the size-adjusted bone mass (BMC for bone area) was normal. Bone Marrow Transplantation (2000) 25, 191–196.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. de Nully Brown P, Olsen JH, Hertz H et al. Trends in survival after childhood cancer in Denmark, 1943–87: a population-based study Acta Paediatr 1995 84: 316–324

    Article  CAS  Google Scholar 

  2. Saarinen UM, Mellander L, Nysom K et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case–control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO) Bone Marrow Transplant 1996 17: 357–363

    CAS  PubMed  Google Scholar 

  3. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission (see comments) New Engl J Med 1994 331: 1253–1258

    Article  CAS  Google Scholar 

  4. Dopfer R, Henze G, Bender-Götze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study Blood 1991 78: 2780–2784

    CAS  PubMed  Google Scholar 

  5. Schroeder H, Gustafsson G, Saarinen-Pihkala UM et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukaemia: a population-based case control study from the Nordic countries Bone Marrow Transplant 1999 23: 555–560

    Article  CAS  Google Scholar 

  6. Shalet SM, Didi M, Ogilvy-Stuart AL et al. Growth and endocrine function after bone marrow transplantation Clin Endocrinol 1995 42: 333–339

    Article  CAS  Google Scholar 

  7. Holm K, Nysom K, Rasmussen MH et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency BoneMarrow Transplant 1996 18: 163–170

    CAS  Google Scholar 

  8. Cohen A, Rovelli A, Bakker B et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT Blood 1999 93: 4109–4115

    CAS  PubMed  Google Scholar 

  9. Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation Blood 1996 87: 3045–3052

    CAS  PubMed  Google Scholar 

  10. Pihkala J, Saarinen UM, Lundstrom U et al. Effects of bone marrow transplantation on myocardial function in children Bone Marrow Transplant 1994 13: 149–155

    CAS  PubMed  Google Scholar 

  11. Nysom K, Holm K, Hesse B et al. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma Arch Dis Child 1996 74: 432–436

    Article  CAS  Google Scholar 

  12. Shalet SM . Radiation and pituitary dysfunction (editorial; comment) New Engl J Med 1993 328: 131–133

    Article  CAS  Google Scholar 

  13. Holmes SJ, Shalet SM . Role of growth hormone and sex steroids in achieving and maintaining normal bone mass Horm Res 1996 45: 86–93

    Article  CAS  Google Scholar 

  14. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K et al. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency Eur J Endocrinol 1997 137: 240–245

    Article  Google Scholar 

  15. Canalis E . Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis J Clin Endocrinol Metab 1996 81: 3441–3447

    CAS  PubMed  Google Scholar 

  16. Ragab AH, Frech RS, Vietti TJ . Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission Cancer 1970 25: 580–585

    Article  CAS  Google Scholar 

  17. Nesbit M, Krivit W, Heyn R, Sharp H . Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems Cancer 1976 37: 1048–1057

    Article  CAS  Google Scholar 

  18. O'Regan S, Melhorn DK, Newman AJ . Methotrexate-induced bone pain in childhood leukemia Am J Dis Child 1973 126: 489–490

    CAS  PubMed  Google Scholar 

  19. Koller A, Fill H, Kurz R et al. Osteopathy due to methotrexate Osterr Kneipp Mag 1976 3: 63–69

    CAS  Google Scholar 

  20. Kelly PJ, Atkinson K, Ward RL et al. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation Transplantation 1990 50: 881–883

    Article  CAS  Google Scholar 

  21. Castelo Branco C, Rovira M, Pons F et al. The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation Maturitas 1996 23: 307–312

    Article  CAS  Google Scholar 

  22. Castañeda S, Carmona L, Carvajal I et al. Reduction of bone mass in women after bone marrow transplantation Calcif Tissue Int 1997 60: 343–347

    Article  Google Scholar 

  23. Bhatia S, Ramsay NK, Weisdorf D et al. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies Bone Marrow Transplant 1998 22: 87–90

    Article  CAS  Google Scholar 

  24. Valimaki MJ, Kinnunen K, Volin L et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin Bone Marrow Transplant 1999 23: 355–361

    Article  CAS  Google Scholar 

  25. Ebeling PR, Thomas DM, Erbas B et al. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation J Bone Miner Res 1999 14: 342–350

    Article  CAS  Google Scholar 

  26. Nysom K, Holm K, Michaelsen KF et al. Bone mass after treatment for acute lymphoblastic leukemia in childhood J Clin Oncol 1998 16: 3752–3760

    Article  CAS  Google Scholar 

  27. Thomas ED, Storb R, Clift A et al. Bone marrow transplantation New Engl J Med 1975 292: 895–902

    Article  CAS  Google Scholar 

  28. Mølgaard C, Thomsen BL, Prentice A et al. Whole body bone mineral content in healthy children and adolescents (see comments) Arch Dis Child 1997 76: 9–15

    Article  Google Scholar 

  29. Nysom K, Mølgaard C, Michaelsen KF . Bone mineral density in the lumbar spine as determined by dual-energy X-ray absorptiometry. Comparison of whole-body scans and dedicated regional scans Acta Radiol 1998 39: 632–637

    Article  CAS  Google Scholar 

  30. Andersson AM, Juul A, Petersen JH et al. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels J Clin Endocrinol Metab 1997 82: 3976–3981

    CAS  PubMed  Google Scholar 

  31. Michaelsen KF, Astrup AV, Mosekilde L et al. The Role of Nutrition in the Prevention of Osteoporosis The Danish Nutrition Council: Copenhagen 1995

    Google Scholar 

  32. Cole TJ, Green PJ . Smoothing reference centile curves: the LMS method and penalized likelihood Stat Med 1992 11: 1305–1319

    Article  CAS  Google Scholar 

  33. SAS Institute Inc . SAS/STAT(R) User's Guide, version 6. 4th rev edn SAS Institute Inc: Cary, NC 1989

    Google Scholar 

  34. Prentice A, Parsons TJ, Cole TJ . Uncritical use of bone mineral density in absorbtiometry may lead to size-related artifacts in the identification of bone mineral determinants Am J Clin Nutr 1994 60: 837–842

    Article  CAS  Google Scholar 

  35. Gilsanz V, Carlson ME, Roe TF, Ortega JA . Osteoporosis after cranial irradiation for acute lymphoblastic leukemia J Pediatr 1990 117: 238–244

    Article  CAS  Google Scholar 

  36. Nussey SS, Hyer SL, Brada M, Leiper AD . Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy (published erratum appears in Acta Paediatr 1995; 84: 620) Acta Paediatr 1994 83: 9–15

    Article  Google Scholar 

  37. Eifel PJ, Donaldson SS, Thomas PR . Response of growing bone to irradiation: a proposed late effects scoring system Int J Radiat Oncol Biol Phys 1995 31: 1301–1307

    Article  CAS  Google Scholar 

  38. Cohen A, Van Lint MT, Uderzo C et al. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood Bone Marrow Transplant 1995 15: 343–348

    CAS  PubMed  Google Scholar 

  39. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M . Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset J Clin Endocrinol Metab 1992 74: 118–123

    CAS  PubMed  Google Scholar 

  40. de Boer H, Blok GJ, van Lingen A et al. Consequences of childhood-onset growth hormone deficiency for adult bone mass J Bone Miner Res 1994 9: 1319–1326

    Article  CAS  Google Scholar 

  41. Vandeweghe M . Can we predict and prevent adult morbidity in males with childhood-onset growth hormone deficiency? Acta Paediatr Suppl 1997 423: 121–123

    Article  CAS  Google Scholar 

  42. Parsons TJ, Prentice A, Smith EA et al. Bone mineral mass consolidation in young British adults J Bone Miner Res 1996 11: 264–274

    Article  CAS  Google Scholar 

  43. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency J Clin Endocrinol Metab 1998 83: 379–381

  44. Behre HM, Kliesch S, Leifke E et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men J Clin Endocrinol Metab 1997 82: 2386–2390

    Article  CAS  Google Scholar 

  45. Hergenroeder AC . Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults J Pediatr 1995 126: 683–689

    Article  CAS  Google Scholar 

  46. Schott AM, Cormier C, Hans D et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study Osteoporos Int 1998 8: 247–254

    Article  CAS  Google Scholar 

  47. Meyer HE, Tverdal A, Falch JA . Risk factors for hip fracture in middle-aged Norwegian women and men Am J Epidemiol 1993 137: 1203–1211

    Article  CAS  Google Scholar 

  48. Joakimsen RM, Fønnebø V, Magnus JH et al. The Tromsø Study: body height, body mass index and fractures Osteoporos Int 1998 8: 436–442

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Tim Cole for helpful comments on LMS modelling of control data. We thank East Danish Research Forum on Health Sciences for statistical advice. Karsten Nysom received financial support from the E Danielsen and Wife Foundation, the Agnes and Poul Friis Foundation, the Jens Christensen and Wife Korna Christensen Foundation, and the Ib Henriksen Foundation. Kirsten Holm received financial support from the Danish Cancer Society (grant No. 92–016). Christian Mølgaard received financial support from FøTEK (Food Technology Research and Development Programme) and the Danish Dairy Research Foundation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nysom, K., Holm, K., Michaelsen, K. et al. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 25, 191–196 (2000). https://doi.org/10.1038/sj.bmt.1702131

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702131

Keywords

This article is cited by

Search

Quick links